TWB announces the creation of EnobraQ

TWB has announced the creation of EnobraQ, a company that develops yeast capable of using CO₂ (atmospheric or of other origins) and transforming it into molecules of interest for the chemical industry. This company, installed at the TWB laboratories, is the product of a TWB research project. Sofinnova Partners, one of Europe’s leaders in venture capital specialized in life sciences and TWB’s partner from the beginning, is the lead investor in EnobraQ.

As a TWB partner, Sofinnova Partners has quickly positioned itself on the Carboyeast project, one of the first research projects selected and self-financed by TWB in 2012 and supported for 3 years by a multidisciplinary team from LISBP (Laboratoire d’Ingénierie des Systèmes Biologiques et des Procédés – INSA Toulouse, France), led by Denis Pompon, a CNRS researcher.

Created at the start of November 2015 and presided by Leopold Demiddeleer, EnobraQ seeks to develop a biological process to capture CO₂ (atmospheric or from industry) using yeasts for the production of chemical compounds. It is based on a breakthrough innovation which consists in designing a synthetic microorganism (Saccharomyces cerevisiae) which, like plants and microalgae, can use CO₂ to produce a wide range of economically interesting chemical molecules.

The creation of a company from TWB self-financed research projects is a result that is highly representative of the movement that TWB seeks to inspire in order to promote research and to speed up the industrialization of processes in biotechnologies.

More information: Press Release